Journal
JOURNAL OF DERMATOLOGY
Volume 41, Issue 6, Pages 539-541Publisher
WILEY-BLACKWELL
DOI: 10.1111/1346-8138.12508
Keywords
false-negative; false-positive; lymph node metastasis; non-melanoma skin cancer; skin surgery
Categories
Funding
- JSPS [25870545]
- National Cancer Center Research and Development Fund [23-A-22]
- Grants-in-Aid for Scientific Research [25870545] Funding Source: KAKEN
Ask authors/readers for more resources
Sentinel lymph node biopsy (SLNB) is a standard care for cutaneous melanoma but its role in cutaneous squamous cell carcinoma (SCC) has not been established. Clinical data was obtained from 54 patients with SCC who received SLNB with the usage of blue dye and radioisotope colloid methods. The positive rate of SLNB in SCC was 7.4%. If the cases were limited to more than T2, the positive rate was 12.9%. Three of 41 patients who was estimated negative LN metastasis by the preoperative tests had micrometastasis (7.3%). Among 13 patients who were suggested to have metastasis in the preoperative tests, only one patient had histological metastasis. One patient with SCC located in the lower lip showed negative SLNB and subsequently developed node recurrence. In conclusion, the efficacy of SLNB in SCC is comparable to that of melanoma in the positive rate. There are two kinds of benefit, avoidance of unnecessary complete lymph node dissection and early detection of metastasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available